Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Emergency Medicine Clinics of North America
|
June 26, 2024
Heat-Related Illnesses
Jonathan Bauman, Susanne Spano, Michelle Storkan
Wilderness & Environmental Medicine
|
November 26, 2025
A Novel Method of Insect Removal from the Auditory Canal
Matthew Lippi, Jonathan Bauman, Pat Plexico, et al.
Journal of Prevention & Intervention in the Community
|
July 25, 2019
Experiential learning through Program Evaluation: Assessing external barriers to Bridgehaven attendance
Meena Kumar, Autumn Truss, Jonathan Bauman, et al.
Expert Review of Clinical Pharmacology
|
January 14, 2014
Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?
Amit S Kalgutkar, Gwendolyn Fate, Mary T Didiuk, et al.
British Journal of Anaesthesia
|
March 14, 2025
Updates on perioperative cessation of SGLT2 inhibitors
Xiao Q Li, Niloofar Mirsaidi, Jonathan Bauman, et al.
Chemical Research in Toxicology
|
June 1, 2007
Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy
Gregory S Walker, James Atherton, Jonathan Bauman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 7, 2012
Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement
Angela Wolford, Thomas S McDonald, Heather Eng, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 13, 2009
Differences in CYP3A4 catalyzed bioactivation of 5-aminooxindole and 5-aminobenzsultam scaffolds in proline-rich tyrosine kinase 2 (PYK2) inhibitors: retrospective analysis by CYP3A4 molecular docking, quantum chemical calculations and glutathione adduct detection using linear ion trap/orbitrap mass spectrometry
Hao Sun, Raman Sharma, Jonathan Bauman, et al.
Chemical Research in Toxicology
|
June 28, 2011
Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States
Antonia F Stepan, Daniel P Walker, Jonathan Bauman, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association
|
May 17, 2024
Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis
Matthew Verdone, Jonathan Bauman, Esben Iversen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Emergency Medicine Clinics of North America
|
June 26, 2024
Heat-Related Illnesses
Jonathan Bauman, Susanne Spano, Michelle Storkan
Wilderness & Environmental Medicine
|
November 26, 2025
A Novel Method of Insect Removal from the Auditory Canal
Matthew Lippi, Jonathan Bauman, Pat Plexico, et al.
Journal of Prevention & Intervention in the Community
|
July 25, 2019
Experiential learning through Program Evaluation: Assessing external barriers to Bridgehaven attendance
Meena Kumar, Autumn Truss, Jonathan Bauman, et al.
Expert Review of Clinical Pharmacology
|
January 14, 2014
Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?
Amit S Kalgutkar, Gwendolyn Fate, Mary T Didiuk, et al.
British Journal of Anaesthesia
|
March 14, 2025
Updates on perioperative cessation of SGLT2 inhibitors
Xiao Q Li, Niloofar Mirsaidi, Jonathan Bauman, et al.
Chemical Research in Toxicology
|
June 1, 2007
Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy
Gregory S Walker, James Atherton, Jonathan Bauman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 7, 2012
Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement
Angela Wolford, Thomas S McDonald, Heather Eng, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 13, 2009
Differences in CYP3A4 catalyzed bioactivation of 5-aminooxindole and 5-aminobenzsultam scaffolds in proline-rich tyrosine kinase 2 (PYK2) inhibitors: retrospective analysis by CYP3A4 molecular docking, quantum chemical calculations and glutathione adduct detection using linear ion trap/orbitrap mass spectrometry
Hao Sun, Raman Sharma, Jonathan Bauman, et al.
Chemical Research in Toxicology
|
June 28, 2011
Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States
Antonia F Stepan, Daniel P Walker, Jonathan Bauman, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association
|
May 17, 2024
Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis
Matthew Verdone, Jonathan Bauman, Esben Iversen, et al.
Page
of 2